ArticleEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2026
Epidemiology of human salmonellosis in Czechia ─ a country with the highest European notification rate, 2012 to 2023.
Article in Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUNDSalmonellosis is the second most notified food-borne infection in Europe. In Czechia (CZ), the notification rate has consistently been above the European average, five times higher in 2013-2022.AIMWe aimed to describe the epidemiology of salmonellosis in CZ in 2012-2023 and identify areas for improving surveillance and public health actions.METHODSWe extracted data on notified salmonellosis cases from the national surveillance system and analysed the dataset for demographic characteristics, hospitalisation, transmission mode and suspected vehicle, descriptively and by chi-square tests and logistic regression.RESULTSIn 2012-2023, 130,990 cases (102.7/100,000 inhabitants) were notified. The overall annual notification rate decreased from 111.7 per 100,000 in 2012-2017 to 94.2 per 100,000 in 2018-2023. Most cases were children and adolescents aged < 15 years (n = 68,370; 52.2%) and most were females (n = 68,425; 52.2%) but males dominated among cases aged < 15 years (35,790/68,370; 52.3%). Few cases were imported (n = 2,627; 2.0%) or outbreak-related (n = 5,361; 4.1%); most were diagnosed in June-October (n = 83,057; 63.4%). Of all notified cases, 22.2% (n = 29,082) were hospitalised. Age of ≥ 40 years was associated with hospitalisation and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.